Assessment and Treatment in Autism Spectrum Disorders: A Focus on Genetics and Psychiatry
Autism spectrum disorders (ASDs) are neurobehavioral disorders characterized by abnormalities in three behavioral domains including social interaction, impaired communication, and repetitive stereotypic behaviors. ASD affects approximately 1% of children and is on the rise with significant genetic m...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Autism Research and Treatment |
Online Access: | http://dx.doi.org/10.1155/2012/242537 |
id |
doaj-f3ad868f51e6455bb186ccd3f63c7eff |
---|---|
record_format |
Article |
spelling |
doaj-f3ad868f51e6455bb186ccd3f63c7eff2020-11-24T20:40:39ZengHindawi LimitedAutism Research and Treatment2090-19252090-19332012-01-01201210.1155/2012/242537242537Assessment and Treatment in Autism Spectrum Disorders: A Focus on Genetics and PsychiatryMerlin G. Butler0Erin L. Youngs1Jennifer L. Roberts2Jessica A. Hellings3Department of Psychiatry and Behavioral Sciences, Kansas University Medical Center, 3901 Rainbow Blvd., MS4015, Kansas City, KS 66160, USASaint Luke’s Cancer Institute, Saint Luke’s Health System, Kansas City, MO 64111, USADepartment of Psychiatry and Behavioral Sciences, Kansas University Medical Center, 3901 Rainbow Blvd., MS4015, Kansas City, KS 66160, USADepartment of Psychiatry and Behavioral Sciences, Kansas University Medical Center, 3901 Rainbow Blvd., MS4015, Kansas City, KS 66160, USAAutism spectrum disorders (ASDs) are neurobehavioral disorders characterized by abnormalities in three behavioral domains including social interaction, impaired communication, and repetitive stereotypic behaviors. ASD affects approximately 1% of children and is on the rise with significant genetic mechanisms underlying these disorders. We review the current understanding of the role of genetic and metabolic factors contributing to ASD with the use of new genetic technology. Fifty percent is diagnosed with chromosomal abnormalities, small DNA deletions/duplications, single-gene conditions, or metabolic disturbances. Genetic evaluation is discussed along with psychiatric treatment and approaches for selection of medication to treat associated challenging behaviors or comorbidities seen in ASD. We emphasize the importance of prioritizing treatment based on target symptom clusters and in what order for individuals with ASD, as the treatment may vary from patient to patient.http://dx.doi.org/10.1155/2012/242537 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Merlin G. Butler Erin L. Youngs Jennifer L. Roberts Jessica A. Hellings |
spellingShingle |
Merlin G. Butler Erin L. Youngs Jennifer L. Roberts Jessica A. Hellings Assessment and Treatment in Autism Spectrum Disorders: A Focus on Genetics and Psychiatry Autism Research and Treatment |
author_facet |
Merlin G. Butler Erin L. Youngs Jennifer L. Roberts Jessica A. Hellings |
author_sort |
Merlin G. Butler |
title |
Assessment and Treatment in Autism Spectrum Disorders: A Focus on Genetics and Psychiatry |
title_short |
Assessment and Treatment in Autism Spectrum Disorders: A Focus on Genetics and Psychiatry |
title_full |
Assessment and Treatment in Autism Spectrum Disorders: A Focus on Genetics and Psychiatry |
title_fullStr |
Assessment and Treatment in Autism Spectrum Disorders: A Focus on Genetics and Psychiatry |
title_full_unstemmed |
Assessment and Treatment in Autism Spectrum Disorders: A Focus on Genetics and Psychiatry |
title_sort |
assessment and treatment in autism spectrum disorders: a focus on genetics and psychiatry |
publisher |
Hindawi Limited |
series |
Autism Research and Treatment |
issn |
2090-1925 2090-1933 |
publishDate |
2012-01-01 |
description |
Autism spectrum disorders (ASDs) are neurobehavioral disorders characterized by abnormalities in three behavioral domains including social interaction, impaired communication, and repetitive stereotypic behaviors. ASD affects approximately 1% of children and is on the rise with significant genetic mechanisms underlying these disorders. We review the current understanding of the role of genetic and metabolic factors contributing to ASD with the use of new genetic technology. Fifty percent is diagnosed with chromosomal abnormalities, small DNA deletions/duplications, single-gene conditions, or metabolic disturbances. Genetic evaluation is discussed along with psychiatric treatment and approaches for selection of medication to treat associated challenging behaviors or comorbidities seen in ASD. We emphasize the importance of prioritizing treatment based on target symptom clusters and in what order for individuals with ASD, as the treatment may vary from patient to patient. |
url |
http://dx.doi.org/10.1155/2012/242537 |
work_keys_str_mv |
AT merlingbutler assessmentandtreatmentinautismspectrumdisordersafocusongeneticsandpsychiatry AT erinlyoungs assessmentandtreatmentinautismspectrumdisordersafocusongeneticsandpsychiatry AT jenniferlroberts assessmentandtreatmentinautismspectrumdisordersafocusongeneticsandpsychiatry AT jessicaahellings assessmentandtreatmentinautismspectrumdisordersafocusongeneticsandpsychiatry |
_version_ |
1716826114757754880 |